RP
Regeneron Pharmaceuticals Portfolio holdings
AUM
$1.49B
This Quarter Return
+20.99%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.49B
AUM Growth
+$251M
(+20%)
Cap. Flow
-$6.3M
Cap. Flow
% of AUM
-0.42%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
TSVT
2seventy bio
TSVT
|
+$6.2M |
| 2 |
BLUE
bluebird bio
BLUE
|
+$102K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alnylam Pharmaceuticals
ALNY
$61.5B
| $1.45B | 97.6% |
4,444,445
| – | – |
|
2
Intellia Therapeutics
NTLA
$1.21B
| $34.7M | 2.34% |
3,702,995
| – | – |
|
3
Adicet Bio
ACET
$66.9M
| $591K | 0.04% |
968,183
| – | – |
|
4
Adverum Biotechnologies
ADVM
$69.5M
| $389K | 0.03% |
180,909
| – | – |
|
|
BLUE
5
DELISTED
bluebird bio
BLUE
| – | – |
-21,000
| Closed | -$102K |
|
|
TSVT
6
DELISTED
2seventy bio
TSVT
| – | – |
-1,254,827
| Closed | -$6.2M |
|